Mednow Inc.
MDNWF · OTC
4/30/2023 | 1/31/2023 | 10/31/2022 | 7/31/2022 | |
|---|---|---|---|---|
| Revenue | $13 | $11 | $10 | $8 |
| % Growth | 12.7% | 16.7% | 20.9% | – |
| Cost of Goods Sold | $11 | $10 | $8 | $7 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 11.6% | 11% | 12.6% | 11.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $5 | $4 | $5 | $5 |
| SG&A Expenses | $5 | $4 | $5 | $5 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $1 |
| Other Operating Expenses | -$3 | $0 | $0 | $0 |
| Operating Expenses | $1 | $5 | $6 | $6 |
| Operating Income | -$3 | -$4 | -$4 | -$5 |
| % Margin | -24.6% | -34.2% | -45.3% | -66.1% |
| Other Income/Exp. Net | -$1 | -$1 | -$1 | -$9 |
| Pre-Tax Income | -$4 | -$4 | -$5 | -$14 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$4 | -$4 | -$5 | -$13 |
| % Margin | -31.4% | -37% | -46.5% | -165.7% |
| EPS | -0.19 | -0.19 | -0.21 | -0.62 |
| % Growth | 0% | 9.5% | 66.1% | – |
| EPS Diluted | -0.19 | -0.19 | -0.21 | -0.62 |
| Weighted Avg Shares Out | 22 | 22 | 22 | 22 |
| Weighted Avg Shares Out Dil | 22 | 22 | 22 | 22 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$3 | -$3 | -$4 | -$5 |
| % Margin | -24.4% | -28.1% | -38.1% | -56.3% |